Skip to content

Are we underestimating the proportion of virally-suppressed patients in the US?

Lopinavir/ritonavir equivalent to nevirapine in Ugandan children

Gene therapy studies show potential for HIV control without drugs

Patrick Younan, Fred Hutchinson Cancer Res Ctr, Seattle, presenting at CROI 2013.

Adding telaprevir improves acute hepatitis C treatment for HIV-positive men

Daniel Fierer, Mt Sinai Medical Center, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Simeprevir & sofosbuvir demonstrates good early cure rate with or without ribavirin

Eric Lawitz, Alamo Medical Research, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Malawi achieves seven-fold increase in ART for pregnant and breastfeeding women

Routine viral load monitoring almost halves risk of virologic failure in 18-month Kenyan study

Dr Frederick Sawe of the Kenya Medical Research Institute presenting at CROI 2013.

Faldaprevir ups interferon response in HIV/HCV co-infection

Douglas Dieterich, Mt Sinai School of Medicine, New York.  © Liz Highleyman / hivandhepatitis.com

Simeprevir pushes HCV cure rate above 75% for HIV/HCV co-infection

Douglas Dieterich, Mt Sinai School of Medicine, New York.  © Liz Highleyman / hivandhepatitis.com